4/16
08:08 am
lab
Standard BioTools Inc. (NASDAQ:LAB): Are Analysts Optimistic? [Yahoo! Finance]
Neutral
Report
Standard BioTools Inc. (NASDAQ:LAB): Are Analysts Optimistic? [Yahoo! Finance]
4/16
08:00 am
lab
Standard BioTools Inc. (NASDAQ: LAB) is now covered by analysts at TD Cowen. They set a "buy" rating and a $3.50 price target on the stock.
Neutral
Report
Standard BioTools Inc. (NASDAQ: LAB) is now covered by analysts at TD Cowen. They set a "buy" rating and a $3.50 price target on the stock.
4/8
08:14 am
lab
Standard BioTools Introduces New High-Throughput Multiplexed Whole Slide Imaging Modalities Set to Redefine the boundaries of Tissue Imaging [Yahoo! Finance]
Medium
Report
Standard BioTools Introduces New High-Throughput Multiplexed Whole Slide Imaging Modalities Set to Redefine the boundaries of Tissue Imaging [Yahoo! Finance]
4/8
08:00 am
lab
Standard BioTools Introduces New High-Throughput Multiplexed Whole Slide Imaging Modalities Set to Redefine the boundaries of Tissue Imaging
Medium
Report
Standard BioTools Introduces New High-Throughput Multiplexed Whole Slide Imaging Modalities Set to Redefine the boundaries of Tissue Imaging
4/4
08:03 am
lab
Standard BioTools Inc. (NASDAQ: LAB) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $3.25 price target on the stock.
Medium
Report
Standard BioTools Inc. (NASDAQ: LAB) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $3.25 price target on the stock.
4/3
04:01 pm
lab
Standard BioTools Announces Multi-Year Strategic Engagement with Bristol Myers Squibb for Use of the SomaScan® Platform for Translational Medicine Research
Low
Report
Standard BioTools Announces Multi-Year Strategic Engagement with Bristol Myers Squibb for Use of the SomaScan® Platform for Translational Medicine Research
4/2
07:27 am
lab
Is Now The Time To Look At Buying Standard BioTools Inc. (NASDAQ:LAB)? [Yahoo! Finance]
Low
Report
Is Now The Time To Look At Buying Standard BioTools Inc. (NASDAQ:LAB)? [Yahoo! Finance]
3/19
06:32 am
lab
Estimating The Fair Value Of Standard BioTools Inc. (NASDAQ:LAB) [Yahoo! Finance]
Low
Report
Estimating The Fair Value Of Standard BioTools Inc. (NASDAQ:LAB) [Yahoo! Finance]
3/18
09:45 am
lab
Standard Biotools exchanges all outstanding Series B convertible preferred stock for common stock [Seeking Alpha]
Low
Report
Standard Biotools exchanges all outstanding Series B convertible preferred stock for common stock [Seeking Alpha]
3/18
08:17 am
lab
Standard BioTools Announces Exchange of All Outstanding Series B Convertible Preferred Stock for Common Stock [Yahoo! Finance]
Low
Report
Standard BioTools Announces Exchange of All Outstanding Series B Convertible Preferred Stock for Common Stock [Yahoo! Finance]
3/18
08:12 am
lab
Standard BioTools Announces Exchange of All Outstanding Series B Convertible Preferred Stock for Common Stock
Medium
Report
Standard BioTools Announces Exchange of All Outstanding Series B Convertible Preferred Stock for Common Stock
3/5
08:37 am
lab
Standard BioTools Inc. (NASDAQ:LAB) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
Medium
Report
Standard BioTools Inc. (NASDAQ:LAB) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
2/28
04:53 pm
lab
Standard BioTools Inc (LAB) Reports Growth and Margin Expansion in FY2023 Despite Economic ... [Yahoo! Finance]
Medium
Report
Standard BioTools Inc (LAB) Reports Growth and Margin Expansion in FY2023 Despite Economic ... [Yahoo! Finance]
2/28
04:13 pm
lab
Standard BioTools Reports Fourth Quarter and Full Year 2023 Financial Results [Yahoo! Finance]
Medium
Report
Standard BioTools Reports Fourth Quarter and Full Year 2023 Financial Results [Yahoo! Finance]
2/28
04:01 pm
lab
Standard BioTools Reports Fourth Quarter and Full Year 2023 Financial Results
Medium
Report
Standard BioTools Reports Fourth Quarter and Full Year 2023 Financial Results
2/26
08:18 am
lab
Standard BioTools and Next Gen Diagnostics Announce Partnership to Provide Complete Automation of Low-Cost Pathogen Sequencing [Yahoo! Finance]
Low
Report
Standard BioTools and Next Gen Diagnostics Announce Partnership to Provide Complete Automation of Low-Cost Pathogen Sequencing [Yahoo! Finance]
2/26
08:00 am
lab
Standard BioTools and Next Gen Diagnostics Announce Partnership to Provide Complete Automation of Low-Cost Pathogen Sequencing
Low
Report
Standard BioTools and Next Gen Diagnostics Announce Partnership to Provide Complete Automation of Low-Cost Pathogen Sequencing
2/22
04:05 pm
lab
Standard BioTools to Participate in Upcoming Investor Conferences
Medium
Report
Standard BioTools to Participate in Upcoming Investor Conferences
2/18
09:30 am
lab
Strong week for Standard BioTools (NASDAQ:LAB) shareholders doesn't alleviate pain of five-year loss [Yahoo! Finance]
Low
Report
Strong week for Standard BioTools (NASDAQ:LAB) shareholders doesn't alleviate pain of five-year loss [Yahoo! Finance]
2/14
08:37 am
lab
Standard BioTools Announces Conference Call and Webcast for Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024 [Yahoo! Finance]
Low
Report
Standard BioTools Announces Conference Call and Webcast for Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024 [Yahoo! Finance]
2/14
08:30 am
lab
Standard BioTools Announces Conference Call and Webcast for Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024
Low
Report
Standard BioTools Announces Conference Call and Webcast for Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024
2/7
08:43 am
lab
Standard BioTools and Navignostics Announce Collaboration Agreement to Advance Imaging Capabilities in Personalized Medicine [Yahoo! Finance]
Medium
Report
Standard BioTools and Navignostics Announce Collaboration Agreement to Advance Imaging Capabilities in Personalized Medicine [Yahoo! Finance]
2/7
08:30 am
lab
Standard BioTools and Navignostics Announce Collaboration Agreement to Advance Imaging Capabilities in Personalized Medicine
Medium
Report
Standard BioTools and Navignostics Announce Collaboration Agreement to Advance Imaging Capabilities in Personalized Medicine